Stockreport

Hims & Hers: The Novo Nordisk Deal Changes Everything [Seeking Alpha]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF Hims generated $2.35B revenue in 2025 (+59% YoY) with $318M EBITDA and $300M operating cash flow, demonstrating strong platform economics. The company ended 2025 with [Read more]